Telomerase Activation in Hematological Malignancies

Author： Ropio Joana   Merlio Jean-Philippe   Soares Paula   Chevret Edith  

Publisher： MDPI

E-ISSN： 2073-4425|7|9|61-61

ISSN： 2073-4425

Source： Genes, Vol.7, Iss.9, 2016-09, pp. : 61-61

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF-κB in Hematological Malignancies

By Imbert Véronique   Peyron Jean-François  

Biomedicines, Vol. 5, Iss. 2, 2017-05 ,pp. : 27-27

MDPI

Access to resources Recommend Favorite

The TET2 interactors and their links to hematological malignancies

By  

IUBMB LIFE, Vol. 67, Iss. 6, 2015-06 ,pp. : 438-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy

By Caivano Antonella   La Rocca Francesco   Laurenzana Ilaria   Trino Stefania   De Luca Luciana   Lamorte Daniela   Del Vecchio Luigi   Musto Pellegrino  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1183-1183

MDPI

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: Advancing Therapeutic Strategies in Hematological and Solid Malignancies

By Ellis Leigh   Pili Roberto  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2441-2469

MDPI

Access to resources Recommend Favorite

Serum 25-Hydroxyvitamin D Levels and Prognosis in Hematological Malignancies: A Systematic Review and Meta-Analysis

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 5, 2015-03 ,pp. : 1999-2005

Karger

Access to resources Recommend Favorite